To evaluate preoperative predictors of enucleation time during en bloc ‘no-touch’ holmium laser enucleation of the prostate (HoLEP) METHODS: We enrolled 135 patients with symptomatic benign prostatic hyperplasia (BPH) treated with en bloc ‘no-touch’ HoLEP from July 2017 to March 2019 by a single surgeon.
Freedom from medication is a common goal for patients undergoing surgical treatment of benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS). Knowing medication discontinuation rates following various forms of transurethral prostatectomy may aid patient counseling and assessing the comparative effectiveness of different approaches.
Multiparametric MRI (mpMRI) has proven to be an essential tool for diagnosis, post-treatment follow-up, aggressiveness assessment, and active surveillance of prostate cancer. Currently, this imaging technique is part of the daily practice in many oncological centres.
(UroToday.com) In an oral presentation in a session examining neoadjuvant versus adjuvant strategies in locally advanced bladder cancer at the 12th European Multidisciplinary Congress on Urological Cancers (EMUC), Dr. Andrea Necchi led a discussion of neoadjuvant strategies in advanced bladder cancer.
(UroToday.com) In a talk presented in the Oral Presentations session of the 12th European Multidisciplinary Congress on Urological Cancers (EMUC), Dr. Michele Marchioni presented recent work examining the management of patients with retroperitoneal recurrences following radical nephrectomy for renal cell carcinoma. This is a relatively uncommon clinical situation and thus, there is minimal data available […]
(UroToday.com) In a talk presented in the Oral Presentations session of the 12th European Multidisciplinary Congress on Urological Cancers (EMUC), Dr. Eduard Roussel presented data on the prognostic value of molecularly subtyping in resected renal cell carcinoma.
(UroToday.com) In a talk presented in the Oral Presentations session of the 12th European Multidisciplinary Congress on Urological Cancers (EMUC), Dr. Henk Luiting presented data regarding the somewhat controversial question of the role of a confirmatory biopsy in patients who are undergoing active surveillance diagnosed on the basis of MRI-informed biopsy.
(UroToday.com) The Fragments of Imaging session at the European Multidisciplinary Congress on Urological Cancers 2020 virtual program included a discussion on the VI-RADS scoring system for bladder cancer presented by Dr. Valeria Panebianco.
(UroToday.com) In a talk presented in the Oral Presentations session of the 12th European Multidisciplinary Congress on Urological Cancers (EMUC), Dr. Dennie Meijer presented work assessing the role of pre-operative PSMA PET/CT among patients who are candidates for radical prostatectomy and extended pelvic lymph node dissection.
(UroToday.com) The European Multidisciplinary Congress on Urological Cancers (EMUC) 2020 virtual meeting featured a round table discussion on the impact of the COVID-19 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic on the management of Genitourinary (GU) cancers, including a presentation by Dr. Hannah Tharmalingam discussing the radiation oncologist’s perspective.
